KALARIS THERAPEUTICS, INC. (KLRS) Capital expenditures 2019–2025
KALARIS THERAPEUTICS, INC. (KLRS) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$200,000FY2025 · since FY2019: $339,000 → $200,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $200,000 | — |
| FY2021 | $26,000 | -88.9% |
| FY2020 | $235,000 | -30.7% |
| FY2019 | $339,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice